Sarepta Archives -

Roche snaps up ex-US rights to Sarepta’s DMD gene therapy

https://pharmaphorum.com/news/roche-snaps-up-ex-us-rights-to-sareptas-dmd-gene-therapy/

Sarepta rebounds on data for limb-girdle muscular dystrophy gene therapy

https://pharmaphorum.com/news/sarepta-rebounds-on-data-for-limb-girdle-muscular-dystrophy-gene-therapy/

FDA says no to Sarepta’s golodirsen, blocking bid to expand its Duchenne stable

https://pharmaphorum.com/news/fda-says-no-to-sarepta-blocking-bid-to-expand-its-duchenne-stable/

ICER posts damning report on Sarepta’s Duchenne drug Exondys 51

https://pharmaphorum.com/news/icer-posts-damning-report-on-sareptas-duchenne-drug-exondys-51/

Sarepta DMD gene therapy could improve patients’ motor function

https://pharmaphorum.com/news/sarepta-dmd-gene-therapy-could-improve-patients-motor-function/

Sarepta dives deeper into gene therapy

https://pharmaphorum.com/news/sarepta-dives-deeper-gene-therapy/

Summit shares plunge nearly 80% after DMD drug fails

https://pharmaphorum.com/news/summit-shares-plunge-dmd-drug-fail/

Pharma collaborates to improve chances of NICE backing Duchenne drugs

https://pharmaphorum.com/news/pharmas-join-improve-duchenne-muscular-dystrophy/

Contrasting fortunes for Duchenne rivals, as PTC fails and Sarepta soars

https://pharmaphorum.com/news/contrasting-fortunes-duchennes-rivals-ptc-fails-sarepta-soars/

Search